Education
| School — Major — Degree | Duration |
|---|---|
|
國立成功大學 — 基礎醫學研究所(畢) — 博士 Doctorate, Institute of Basic Medical Sciences, National Cheng Kung University |
2007/09 — 2014/06 |
|
中山醫學大學 — 免疫學研究所(畢) — 碩士 Master, Institute of Immunology, Chung Shan Medical University |
2005/09 — 2007/06 |
|
私立中華醫事學院 — 醫事技術系(畢) — 學士 Bachelor, Department of Medical technology, Chung Hwa University of Medical Technology |
2000/09 — 2002/06 |
Intramural Experience
| Office/Department/Institute | Position | Duration |
|---|---|---|
| 生物科技學系 Department of Biotechnology | Assistant Professor | 2022/08/01 — |
Extramural Experience
Discipline
| NO | Discipline | Expertise |
|---|---|---|
| 1 | 生物醫農類 Biology, Medicine and Agriculture | 醫學之生化及分子生物 Medical Biochemistry and Molecular Biology |
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
Area(s) of Expertise & Research
表觀遺傳學 腫瘤生物學 腫瘤免疫學
Epigenetics Cancer biology Tumor Immunology
Publication
| NO | Publication |
|---|---|
| 1 | Rab37可介導PD-1的運輸和膜表達以維持肺癌中T細胞的衰竭 Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer. |
| 2 | Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion |
| 3 | Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers. Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers. |
| 4 | Revealing potential Rab proteins participate in regulation of secretory autophagy machinery Revealing potential Rab proteins participate in regulation of secretory autophagy machinery |
| 5 | 腫瘤微環境中傳統及非傳統囊泡分泌途徑的最新進展 Recent advances in conventional and unconventional vesicular secretion pathways in the tumor microenvironment |
| 6 | Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. |
Project
| NO |
YEAR — Source — No — Type
Project Name
|
Duration |
|---|---|---|
| 1 |
112 — N 國科會(原科技部) — NSTC113-2320-B-037-004 — 1 個人型
探討niclosamide舊藥新用對肺腫瘤微環境中免疫細胞CCL2/CCR2路徑之分子調控機轉( )
|
2024/01/01 ~ 2024/10/31 |
| 2 |
112 — Q 新聘教師計畫(校內) — KMU-Q113006 —
探討FOXM1在肺癌微環境的癌細胞增生及轉移過程中所扮演的角色( )
|
2024/01/01 ~ 2024/12/31 |
| 3 |
111 — Z 大專學生研究計畫及博士後 — NSTC112-2813-C-037-063-B — 8 大專學生研究計畫
112年度大專學生研究計畫-李怡禎(生技3)( )
|
2023/07/01 ~ 2024/02/29 |